ADIL
Adial Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.12
+6.91%6
Insider buys (3m)
0
Insider sells (3m)
$106.4K
Net value (3m)
+208.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 16, 2026 | Coastlands Capital LP · 10 percent owner | Purchase | 1,233 | $2.75 |
| Jul 16, 2026 | Coastlands Capital LP · 10 percent owner | Purchase | 2,000 | $2.65 |
| Jul 13, 2026 | Coastlands Capital LP · 10 percent owner | Purchase | 10,053 | $2.79 |
| Jul 13, 2026 | Coastlands Capital LP · 10 percent owner | Purchase | 1,700 | $2.70 |
| Jul 1, 2026 | Coastlands Capital LP · 10 percent owner | Purchase | 25,000 | $2.60 |
| Jun 16, 2026 | Davidson Matt · director, officer: Chief Development Officer | A-Award | 61,647 | $0.00 |
| Jun 16, 2026 | Young Wendy B. · director | Purchase | 36,378 | $0.00 |
| Jun 16, 2026 | Davidson Matt · director, officer: Chief Development Officer | A-Award | 101 | $0.00 |
| Jun 16, 2026 | Davidson Matt · director, officer: Chief Development Officer | A-Award | 1,822 | $0.00 |
| Jun 16, 2026 | Davidson Matt · director, officer: Chief Development Officer | A-Award | 232,417 | $0.00 |
| Jun 16, 2026 | Davidson Matt · director, officer: Chief Development Officer | A-Award | 3,427 | $0.00 |
| Apr 9, 2026 | Schuyler Kevin · director | A-Award | 9,185 | $0.00 |
| Apr 9, 2026 | Shah Vinay · officer: Chief Financial Officer | A-Award | 17,325 | $0.00 |
| Apr 9, 2026 | Gilliland Robertson H. · director | A-Award | 9,185 | $0.00 |
| Apr 9, 2026 | Claiborne Cary J · director, officer: Chief Executive Officer | A-Award | 37,985 | $0.00 |
| Apr 9, 2026 | Goodman Tony · director, officer: Chief Operating Officer | A-Award | 26,510 | $0.00 |
| Apr 9, 2026 | Anderson J. Kermit · director | A-Award | 9,185 | $1.64 |
| Jun 2, 2025 | Shah Vinay · officer: Chief Financial Officer | A-Award | 9,000 | $0.69 |
| Jun 2, 2025 | Claiborne Cary J · director, officer: Chief Executive Officer | A-Award | 138,000 | $0.69 |
| Jun 2, 2025 | Goodman Tony · director, officer: Chief Operating Officer | A-Award | 94,000 | $0.69 |
| Jun 2, 2025 | Gilliland Robertson H. · director | A-Award | 28,000 | $0.69 |
| Jun 2, 2025 | Anderson J. Kermit · director | A-Award | 28,000 | $0.69 |
| Jun 2, 2025 | Newman James W. Jr. · director | A-Award | 28,000 | $0.69 |
| Jun 2, 2025 | Schuyler Kevin · director | A-Award | 28,000 | $0.69 |
| Dec 5, 2024 | Claiborne Cary J · director, officer: Chief Executive Officer | A-Award | 350,000 | $1.15 |
| Nov 18, 2024 | Shah Vinay · officer: Chief Financial Officer | A-Award | 40,000 | $1.06 |
| Mar 27, 2024 | Schuyler Kevin · director | A-Award | 12,000 | $1.35 |
| Mar 27, 2024 | Gilliland Robertson H. · director | A-Award | 12,000 | $1.35 |
| Mar 27, 2024 | Newman James W. Jr. · director | A-Award | 12,000 | $1.35 |
| Mar 27, 2024 | Truluck Joseph · officer: Chief Financial Officer | A-Award | 25,000 | $1.35 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 2Reduced 8Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 29,547 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 24,249 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 5,879 | May 8, 2026 |
| MANCHESTER CAPITAL MANAGEMENT LLC | Reduced | 1,923 | May 11, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 1,356 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 1,110 | May 13, 2026 |
| UBS GROUP AG | Reduced | 542 | May 5, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 361 | May 15, 2026 |
| MORGAN STANLEY | Increased | 50 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | Reduced | 47 | Apr 28, 2026 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | New Position | 15 | May 11, 2026 |
| WELLS FARGO & COMPANY/MN | Reduced | 6 | Jul 8, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | New Position | 4 | May 7, 2026 |
| HARBOUR INVESTMENTS, INC. | Reduced | 3 | May 15, 2026 |
| ABOUND WEALTH MANAGEMENT | Reduced | 1 | Apr 10, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 16, 2026